التفاصيل البيبلوغرافية
| العنوان: |
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan |
| المؤلفون: |
Huang, Yen-Hsiang, Hsu, Kuo-Hsuan, Tseng, Jeng-Sen, Yang, Tsung-Ying, Chen, Kun-Chieh, Su, Kang-Yi, Yu, Sung-Liang, Chen, Jeremy J. W., Chang, Gee-Chen |
| المصدر: |
Targeted Oncology ; volume 17, issue 3, page 295-306 ; ISSN 1776-2596 1776-260X |
| بيانات النشر: |
Springer Science and Business Media LLC |
| سنة النشر: |
2022 |
| مصطلحات موضوعية: |
Pharmacology (medical), Cancer Research, Oncology |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1007/s11523-022-00878-x |
| DOI: |
10.1007/s11523-022-00878-x.pdf |
| DOI: |
10.1007/s11523-022-00878-x/fulltext.html |
| الإتاحة: |
https://doi.org/10.1007/s11523-022-00878-xTest |
| حقوق: |
https://creativecommons.org/licenses/by-nc/4.0Test/ ; https://creativecommons.org/licenses/by-nc/4.0Test/ |
| رقم الانضمام: |
edsbas.D185BDDB |
| قاعدة البيانات: |
BASE |
